Efficacy of zilucoplan in patients with generalized myasthenia gravis without prior immunoglobulin or plasma exchange in the RAISE study

Important Information Related to Your Request:

The material below is provided in response to your specific search for information on UCBCOMPASS^® and may contain information that is not part of the FDA-approved Prescribing Information. UCB, Inc. does not recommend or endorse the use of its products in a manner not consistent with the approved Prescribing Information. Please review the Full Prescribing Information.

Efficacy of zilucoplan in patients with generalized myasthenia gravis without prior immunoglobulin or plasma exchange treatment in the RAISE study was a subgroup analysis, therefore results should be interpreted with caution.